Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
JoVE Journal
Medicine

A subscription to JoVE is required to view this content.

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
 

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Article DOI: 10.3791/55833-v 06:34 min December 1st, 2017
December 1st, 2017

Chapters

Summary

The presented protocols describe how to perform a hemagglutination inhibition assay to quantify influenza-specific antibody titers from serum samples of influenza vaccine recipients. The first assay determines optimal viral antigen concentrations by hemagglutination. The second assay quantifies influenza-specific antibody titers by hemagglutination inhibition.

Tags

Hemagglutination Inhibition Assay Influenza-specific Antibody Titers Vaccine-mediated Immunity Neutralizing Antibodies Mouse Serum Culture Supernatants 96 Well Microtiter Plates PBS Antigen Solution RDE Treated Serum Samples Antiserum Serial Dilutions
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter